Search

Guo H Feng

from Winchester, MA
Age ~66

Guo Feng Phones & Addresses

  • 19 Sheridan Cir, Winchester, MA 01890 (781) 721-1098
  • 1558 Carnavon Way, San Jose, CA 95131
  • Chestnut Hill, MA
  • 3035 Alma St, Palo Alto, CA 94306 (650) 813-9261
  • Stanford, CA
  • Madison, WI
  • Lexington, MA
  • 19 Sheridan Cir, Winchester, MA 01890

Work

Position: Food Preparation and Serving Related Occupations

Education

Degree: Associate degree or higher

Resumes

Resumes

Guo Feng Photo 1

Pharmacologist At Agile

View page
Location:
Winchester, MA
Industry:
Pharmaceuticals
Work:
Agile-1
Pharmacologist at Agile

Pfizer 2005 - 2011
Senior Scientist

Massachusetts General Hospital 2001 - 2005
Research Scientist

Pfizer 2001 - 2005
Rpm
Education:
Graduate School, Acdemia Sinica
Graduate School
Wuhan University
Skills:
Assay Development
Pharmacology
Biomarkers
In Vivo
Cell
Drug Discovery
In Vitro
High Throughput Screening
Interests:
Chen Style Taiji Sword 47 Form
Combined 48 Form
Chen Taiji Laojia 74 Form
Traditional Yang 85 Form
Competition 40 Form
Practicing Tai Chi
Simplified 24 Form
Guo Feng Photo 2

Pharmacologist At Agile 1

View page
Location:
Greater Boston Area
Industry:
Pharmaceuticals
Guo Feng Photo 3

Guo Feng

View page

Publications

Amazon

Guo Feng. prose (overseas Chinese prose Series 91 version 1 1 India India one thousand)(Chinese Edition)

View page
Author

GUO FENG

Binding

Paperback

Publisher

Baihua Literature and Art

ISBN #

7530607073

EAN Code

9787530607077

ISBN #

10

Us Patents

Method For Recombining Polynucleotides

View page
US Patent:
20020119535, Aug 29, 2002
Filed:
Dec 21, 2000
Appl. No.:
09/746432
Inventors:
Steven Slater - Acton MA, US
Wing-On Ng - Daly City CA, US
Guo Feng - Brookline MA, US
Alex Monreal - Boston MA, US
International Classification:
C12P019/34
C07H021/04
US Classification:
435/091200, 536/023100
Abstract:
Methods for recombining a polynucleotides of interest comprising the step of generating a recombinant polynucleotide by PCR amplification using as a template a pool of oligonucleotides having a chain terminating agent, e.g. ddNTP, at the 3′ end. Such oligonucleotides are preferably short, e.g. to provide for a higher degree of recombination. The PCR amplification is preferably carried out under conditions inducing mutagenesis in the amplified polynucleotide product. Recombined and mutagenized polynucleotides can be used to rapidly evolve cells and/or organisms to enhance or depress a phenotype of interest.
Guo H Feng from Winchester, MA, age ~66 Get Report